Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2022-12-16

First gene therapy to treat haemophilia B

View source ↗

Summary

The European Medicines Agency approved the first gene therapy designed to treat haemophilia B, marking a milestone in genetic treatment for this disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications